⌘K

Login Start Free

Home/Filings/4/A/0001493152-21-016687

4/A//SEC Filing

LaFrence Andrew D.C. 4/A

Accession 0001493152-21-016687

CIK 0001349929other

View on SEC.gov Company Profile

Filed

Jul 12, 8:00 PM ET

Accepted

Jul 13, 9:00 AM ET

Size

7.3 KB

Accession

0001493152-21-016687

Insider Transaction Report

Form 4/AAmended

Period: 2021-03-30

Vyant Bio, Inc.VYNT

LaFrence Andrew D.C.

Chief Financial Officer

Transactions

Other
Common Stock, $0.0001 par value
2021-03-30+26,825→ 26,825 total(indirect: By Trust)
Other
Common Stock, $0.0001 par value
2021-03-30+29,292→ 29,292 total

Footnotes (1)

[F1]This amended Form 4 is being filed to correct the number of shares of the Issuer's common stock, $0.0001 par value (the "Common Stock") issued pursuant to the merger on March 30, 2021.

Documents

1 file

4
ownership.xml

Issuer

Vyant Bio, Inc.

CIK 0001349929

Entity typeother

Related Parties

1

filerCIK 0001850633

Filing Metadata

Form type: 4/A
Filed: Jul 12, 8:00 PM ET
Accepted: Jul 13, 9:00 AM ET
Size: 7.3 KB

View on SEC.gov